• Cell Counting Kit-8 Plus: Advanced Tetrazolium Salt Assay Wo

  2026-05-19

  Cell Counting Kit-8 (CCK-8) Plus stands out for its sensitivity and rapid turnaround in cell proliferation and cytotoxicity assays, enabling robust experimental designs—even in challenging models. This article explores best practices, advanced protocols, and troubleshooting strategies that leverage CCK-8 Plus for reproducible, high-impact results in modern biomedical research.

• Mechanistic Precision and Translational Impact of Cell Count

  2026-05-18

  This thought-leadership article bridges mechanistic understanding and translational strategy, spotlighting the Cell Counting Kit-8 (CCK-8) Plus as a transformative tool for cell proliferation and cytotoxicity research. Integrating recent mechanistic findings on anti-inflammatory pathways with competitive benchmarking and actionable protocol guidance, the article offers a roadmap for translational researchers seeking robust, clinically relevant cell-based data.

• Gramine Triggers Ferroptosis in TNBC via CUL3–MTDH Ubiquitin

  2026-05-18

  The referenced study uncovers a novel mechanism by which the natural alkaloid gramine inhibits triple-negative breast cancer (TNBC) proliferation through ferroptosis, mediated by CUL3-dependent ubiquitination of MTDH. These findings provide a mechanistic framework for future therapeutic strategies targeting ferroptosis pathways in aggressive breast cancers.

• Precision Cell Viability: CCK-8 in Translational Discovery

  2026-05-17

  This thought-leadership article explores how mechanistic insights from the CCK-8 assay can empower translational researchers to bridge in vitro discovery with clinical innovation. By dissecting its biochemical rationale, benchmarking performance, and contextualizing its pivotal role in antifungal nanotherapy evaluation, the article delivers actionable guidance for robust, high-sensitivity cellular assays. APExBIO's Cell Counting Kit-8 (CCK-8) is positioned as a transformative tool for optimizing cell viability and cytotoxicity workflows, with evidence-labeled recommendations for protocol design and translational alignment.

• ORM2 Regulates Pancreatic Fibrosis via Autophagy and ZG16 in

  2026-05-16

  This study identifies ORM2 as a key regulator of pancreatic fibrosis in chronic pancreatitis by modulating autophagy through ZG16 interaction. The findings provide mechanistic insight into PSC activation and outline ORM2 as a potential antifibrotic target, with broad implications for pancreatic function research.

• Sulfated CCK-8 Induces Anxiety-like Behavior in Zebrafish

  2026-05-15

  This study demonstrates that intracerebroventricular administration of two molecular forms of sulfated cholecystokinin octapeptide (CCK-8s) can reliably induce anxiety-like behaviors in zebrafish via CCK receptor signaling. The findings establish zebrafish as a robust model for dissecting neuropeptide-mediated anxiety and provide a foundation for translational research on CCK1R and CCK2R pathways.

• Ethacridine Lactate Monohydrate: Precision Antiseptic for Ep

  2026-05-15

  Explore the advanced scientific utility of Ethacridine lactate monohydrate in epigenetic and chromatin-based research. This cornerstone article details its mechanism, unique molecular profile, and strategic role in safeguarding next-generation assays.

• Structural Insights into Human EMC-VDAC Interaction via Cryo

  2026-05-14

  This study elucidates the structural basis of the human ER membrane protein complex (EMC) and its interaction with the voltage-dependent anion channel (VDAC) using high-resolution cryo-electron microscopy. The findings reveal a gating plug mechanism within the EMC that modulates its multifunctionality, advancing our understanding of membrane protein biogenesis and its disease relevance.

• Anti Reverse Cap Analog: Maximizing Synthetic mRNA Translati

  2026-05-14

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, enables orientation-specific mRNA capping for double the translational efficiency versus conventional analogs. This article translates bench evidence into protocol-ready guidance for mRNA therapeutics, synthetic biology, and advanced in vitro transcription workflows.

• DDX21-NAT10 Axis Drives ac4C Modification in CRC Metastasis

  2026-05-13

  This study uncovers how DDX21 competitively binds SIRT7 to upregulate NAT10, leading to increased ac4C mRNA modification and enhanced metastasis and angiogenesis in colorectal cancer. The mechanistic insights into DDX21-mediated mRNA stabilization highlight new targets for therapeutic intervention.

• CUDC-907: Technical Guide to Dual PI3K and HDAC Inhibition

  2026-05-13

  CUDC-907 addresses the need for precise, simultaneous inhibition of PI3K and HDAC signaling in cancer research. It is intended exclusively for controlled in vitro studies, particularly those focused on cell cycle arrest and apoptosis mechanisms in established cancer cell models. This compound is not suitable for diagnostic, therapeutic, or clinical applications.

• Applied Insights: Bromodomain Inhibitor (+)-JQ1 in Translati

  2026-05-12

  Bromodomain Inhibitor, (+)-JQ1 enables precise, selective targeting of BET proteins, empowering researchers to probe epigenetic regulation in cancer, inflammation, and stem cell differentiation. This article translates current research breakthroughs, including super-enhancer-driven adipogenesis, into actionable protocols and troubleshooting guidance for maximizing experimental impact.

• VX-765: Advanced Caspase-1 Inhibition for Inflammation Resea

  2026-05-12

  VX-765 delivers precise, selective inhibition of caspase-1, enabling researchers to dissect inflammasome signaling and pyroptosis with unparalleled clarity. Its robust performance in both cellular and in vivo models—combined with workflow-ready solubility and reproducibility—makes it essential for cutting-edge studies of inflammatory diseases and cell death.

• Ceftazidime: Third-Generation Cephalosporin for Resistant In

  2026-05-11

  Ceftazidime is a third-generation cephalosporin with broad-spectrum activity, including notable efficacy against Pseudomonas aeruginosa. It is highly resistant to β-lactamase hydrolysis, making it a key agent for Gram-negative infection research and the treatment of bacterial pneumonia and bronchitis. This article reviews its mechanism, evidence benchmarks, and best practices for laboratory integration.

• Ceruletide in Pancreatic Fibrosis Models: Autophagy Insights

  2026-05-11

  Discover how Ceruletide empowers next-generation pancreatic fibrosis and gastrointestinal physiology studies. This in-depth article highlights unique autophagy-focused insights and practical assay strategies for high-impact research.

617 records 8/42 page Previous Next First page 上5页 678910 下5页 Last page